PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $824,000 | -55.7% | 333,728 | -43.7% | 0.32% | -5.6% |
Q2 2016 | $1,862,000 | -29.7% | 592,849 | -25.5% | 0.34% | -10.5% |
Q1 2016 | $2,649,000 | -54.6% | 795,409 | -51.8% | 0.38% | -39.3% |
Q4 2015 | $5,838,000 | +48.7% | 1,649,083 | +111.3% | 0.63% | +66.4% |
Q3 2015 | $3,925,000 | +4.8% | 780,281 | +34.0% | 0.38% | +3.3% |
Q2 2015 | $3,745,000 | -7.4% | 582,438 | +1.3% | 0.37% | -7.6% |
Q1 2015 | $4,044,000 | +183.2% | 574,801 | +210.3% | 0.40% | +191.2% |
Q4 2014 | $1,428,000 | +203.2% | 185,225 | +193.9% | 0.14% | +231.7% |
Q3 2014 | $471,000 | -87.8% | 63,029 | -84.1% | 0.04% | -86.5% |
Q2 2014 | $3,847,000 | +85.5% | 397,392 | +59.2% | 0.30% | +121.2% |
Q1 2014 | $2,074,000 | -61.9% | 249,550 | -61.3% | 0.14% | -46.7% |
Q4 2013 | $5,437,000 | +126.5% | 644,214 | +114.0% | 0.26% | +135.8% |
Q3 2013 | $2,400,000 | -63.9% | 301,078 | -65.1% | 0.11% | -61.1% |
Q2 2013 | $6,653,000 | – | 861,769 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |